A Phase 1 Study of Novel GS-9973 Tablet Formulations to Evaluate the Effect of Acid Reducing Agents, Relative Bioavailability, and Food Effect on GS-9973 Pharmacokinetics
Clinical trial NCT01841489 · COMPLETED
Trial details
- NCT number
- NCT01841489
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2013-08-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.